RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia

Human Molecular Genetics

Volumn 9, Issue 15, 2000, Pages 2297-2304

  Beghini, Alessandro ^a   Ripamonti, Carla B ^a   Peterlongo, Paolo ^a   Roversi, Gaia ^a   Cairoli, Roberto ^b   Morra, Enrica ^b   Larizza, Lidia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CD34 ANTIGEN; COMPLEMENTARY DNA; GUANINE; MESSENGER RNA; PROTEIN TYROSINE PHOSPHATASE; STEM CELL FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ALTERNATIVE RNA SPLICING; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRON; LEUKEMOGENESIS; MOLECULAR CLONING; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROCESSING; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EDITING; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS;

EID: 0034703285     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.hmg.a018921     Document Type: Article

References (45)

1. Gene regulation by mRNA editing
2. Glutamate receptor RNA editing in vitro by enzymatic conversion of adenine to inosine
3. Editing of glutamate receptor subunit B pre-mRNA in vitro by site-specific deamination of adenosine
4. A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors
5. RNA editing in the Wilms' tumor susceptibility gene, WT1
6. Protein tyrosine phosphatase containing SH2 domains: Characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13
7. Involvement of SHP-1, a phosphotyrosine phosphatase, during myeloid cell differentiation in acute promyelocytic leukemia cell lines
8. Hematopoietic cell phosphatase associates with the interleukine-3 (IL-3) receptor β chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis
9. Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1
10. Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: Detection of potential HCP substrates in GM-CSF signal transduction
11. Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice
12. Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1
13. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice
14. Identification of PTP1C mutation as the genetic defect in motheaten and viable motheaten: A step toward defining the roles of protein tyrosine phosphatases in the regulation of hematopoietic cell differentiation and function
15. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene
16. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (HCPH) gene
17. Association of hematopoietic cell phosphatase with c-kit after stimulation with c-kit ligand
18. SHP-1 binds and negatively modulates the c-kit receptor by interaction with tyrosine 569 in the c-kit juxtamembrane domain
19. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals
20. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells
21. Modulation of Kit/stem cell factor receptor-induced signaling by protein kinase C
22. Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase
23. Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase
24. A specific combination of substrates is involved in signal transduction by the kit-encoded receptor
25. The MATK tyrosine kinase interacts in a specific and SH2-dependent manner with c-Kit
26. Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1
27. Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1
28. c-kit activating mutations and mast cell proliferation in human leukemia
29. C-kit mutations in core binding factor leukemias
30. C-Kit proto oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia
31. Proliferation of human myeloid leukemia cell line associated with the tyrosine-phosphorylation and activation of the proto-oncogene c-kit product
32. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1
33. Isolation of a src homology 2-containing tyrosine phosphatase
34. RNA editing and alternative splicing generate mRNA transcript diversity from the Drosophila 4f-rnp locus
35. Evidence that translation reinitiation abrogates nonsense-mediated mRNA decay in mammalian cells
36. The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing
37. A rule for termination-codon position within intron-containing genes: When nonsense affects RNA abundance
38. Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1
39. Murine SHP-1 splice variants with altered Src homology 2 (SH2) domains
40. Oncogenic activation of v-kit involves deletion of a putative tyrosine-substrate interaction site
41. Retention of wild-type p53 in tumors from p53 heterozygous mice: Reduction of p53 dosage can promote cancer formation
42. The murine gene p27(kip1) is haplo-insufficient for tumor suppression
43. Genetic and biochemical evidence that haploinsufficiency of the nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo
44. Human protein tyrosine phosphatase 1C (PTPN6) gene structure: Alternate promoter usage and exon skipping generate multiple transcripts